Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21313809rdf:typepubmed:Citationlld:pubmed
pubmed-article:21313809lifeskim:mentionsumls-concept:C0038435lld:lifeskim
pubmed-article:21313809lifeskim:mentionsumls-concept:C0680730lld:lifeskim
pubmed-article:21313809lifeskim:mentionsumls-concept:C0245561lld:lifeskim
pubmed-article:21313809lifeskim:mentionsumls-concept:C0699900lld:lifeskim
pubmed-article:21313809lifeskim:mentionsumls-concept:C0243125lld:lifeskim
pubmed-article:21313809lifeskim:mentionsumls-concept:C0008562lld:lifeskim
pubmed-article:21313809lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:21313809lifeskim:mentionsumls-concept:C1148554lld:lifeskim
pubmed-article:21313809lifeskim:mentionsumls-concept:C1706128lld:lifeskim
pubmed-article:21313809pubmed:issue6lld:pubmed
pubmed-article:21313809pubmed:dateCreated2011-2-14lld:pubmed
pubmed-article:21313809pubmed:abstractTextA stability-indicating HPLC assay method was developed for the quantitative determination of duloxetine (DLX) in a pharmaceutical dosage form in the presence of its degradation products, and kinetic determinations were evaluated in acid conditions and UV-C radiation exposure. Chromatographic separation was achieved by use of an ACE C18 column (250 x 4.0 mm id, 5 microm particle size). The mobile phase was prepared by mixing aqueous 50 mM potassium phosphate buffer (pH 6.0 containing 0.3% triethylamine) and acetonitrile (60 + 40, v/v). DLX was rapidly degraded in an acid medium and in the presence of hydrogen peroxide and UV-C radiation; it was more stable in alkaline medium. The described method was linear over a range of 4.0-14.0 microg/mL for determination of DLX (r = 0.9998). The precision was demonstrated by the RSD of intraday (0.79-1.07%) and interday (0.85%) studies. The mean recovery was found to be 100.56%. The acid degradation of DLX in 0.1 M HCI solution showed an apparent zero-order kinetics (k = 0.177 microg/mL/min), and the photodegradation demonstrated an apparent first-order kinetics (k = 0.082 microg/mL/min). The developed method was found to be simple, specific, robust, linear, precise, and accurate for the determination of DLX in enteric-coated pellets.lld:pubmed
pubmed-article:21313809pubmed:languageenglld:pubmed
pubmed-article:21313809pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21313809pubmed:citationSubsetIMlld:pubmed
pubmed-article:21313809pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21313809pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21313809pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21313809pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21313809pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21313809pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21313809pubmed:statusMEDLINElld:pubmed
pubmed-article:21313809pubmed:issn1060-3271lld:pubmed
pubmed-article:21313809pubmed:authorpubmed-author:SchapovalElfr...lld:pubmed
pubmed-article:21313809pubmed:authorpubmed-author:SteppeMartinMlld:pubmed
pubmed-article:21313809pubmed:authorpubmed-author:PaimClésio...lld:pubmed
pubmed-article:21313809pubmed:authorpubmed-author:GomesPatrícia...lld:pubmed
pubmed-article:21313809pubmed:authorpubmed-author:WingertNathal...lld:pubmed
pubmed-article:21313809pubmed:issnTypePrintlld:pubmed
pubmed-article:21313809pubmed:volume93lld:pubmed
pubmed-article:21313809pubmed:ownerNLMlld:pubmed
pubmed-article:21313809pubmed:authorsCompleteYlld:pubmed
pubmed-article:21313809pubmed:pagination1829-35lld:pubmed
pubmed-article:21313809pubmed:meshHeadingpubmed-meshheading:21313809...lld:pubmed
pubmed-article:21313809pubmed:meshHeadingpubmed-meshheading:21313809...lld:pubmed
pubmed-article:21313809pubmed:meshHeadingpubmed-meshheading:21313809...lld:pubmed
pubmed-article:21313809pubmed:meshHeadingpubmed-meshheading:21313809...lld:pubmed
pubmed-article:21313809pubmed:meshHeadingpubmed-meshheading:21313809...lld:pubmed
pubmed-article:21313809pubmed:meshHeadingpubmed-meshheading:21313809...lld:pubmed
pubmed-article:21313809pubmed:meshHeadingpubmed-meshheading:21313809...lld:pubmed
pubmed-article:21313809pubmed:meshHeadingpubmed-meshheading:21313809...lld:pubmed
pubmed-article:21313809pubmed:meshHeadingpubmed-meshheading:21313809...lld:pubmed
pubmed-article:21313809pubmed:meshHeadingpubmed-meshheading:21313809...lld:pubmed
pubmed-article:21313809pubmed:meshHeadingpubmed-meshheading:21313809...lld:pubmed
pubmed-article:21313809pubmed:meshHeadingpubmed-meshheading:21313809...lld:pubmed
pubmed-article:21313809pubmed:meshHeadingpubmed-meshheading:21313809...lld:pubmed
pubmed-article:21313809pubmed:meshHeadingpubmed-meshheading:21313809...lld:pubmed
pubmed-article:21313809pubmed:meshHeadingpubmed-meshheading:21313809...lld:pubmed
pubmed-article:21313809pubmed:articleTitleStress degradation studies and kinetic determinations of duloxetine enteric-coated pellets by HPLC.lld:pubmed
pubmed-article:21313809pubmed:affiliationUniversidade Federal do Rio Grande do Sul (UFRGS), Faculdade de Farmácia, Programa de Pós-Graduação em Ciências Farmacêuticas, Porto Alegre, RS, Brazil. patriciagomes0@yahoo.com.brlld:pubmed
pubmed-article:21313809pubmed:publicationTypeJournal Articlelld:pubmed